J. Michael Pearson

Overview Valeant Pharmaceuticals International6 Orion Marine Group8

2015 2014 2013 2012 2011 2010

2013 - Valeant Pharmaceuticals International

In 2013, J. Michael Pearson earned a total compensation of $7M as Chief Executive Officer at Valeant Pharmaceuticals International, a 14% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan	$4,789,531
Salary	$1,750,000
Other	$458,203
Total	$6,997,734

Pearson received $4.8M in non-equity incentive plan, accounting for 68% of the total pay in 2013.

Pearson also received $1.8M in salary and $458.2K in other compensation.

Rankings

In 2013, J. Michael Pearson's compensation ranked 794th out of 12,286 executives tracked by ExecPay. In other words, Pearson earned more than 93.5% of executives.

Classification	Ranking	Percentile
All	794 out of 12,286	94th
Division Manufacturing	257 out of 4,612	94th
Major group Chemicals And Allied Products	70 out of 1,462	95th
Industry group Drugs	45 out of 1,156	96th
Industry Pharmaceutical Preparations	41 out of 890	95th

Source: SEC filing on April 29, 2016.

2014 2012

Pearson's colleagues

We found seven more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2013.